AMP-deaminata 3 je enzim koji je kod ljudi kodiran genom AMPD3.[5][6]

AMPD3
Identifikatori
AliasiAMPD3
Vanjski ID-jeviOMIM: 102772 MGI: 1096344 HomoloGene: 408 GeneCards: AMPD3
Lokacija gena (čovjek)
Hromosom 11 (čovjek)
Hrom.Hromosom 11 (čovjek)[1]
Hromosom 11 (čovjek)
Genomska lokacija za AMPD3
Genomska lokacija za AMPD3
Bend11p15.4Početak10,308,313 bp[1]
Kraj10,507,579 bp[1]
Lokacija gena (miš)
Hromosom 7 (miš)
Hrom.Hromosom 7 (miš)[2]
Hromosom 7 (miš)
Genomska lokacija za AMPD3
Genomska lokacija za AMPD3
Bend7 E3|7 57.85 cMPočetak110,367,413 bp[2]
Kraj110,411,612 bp[2]
Obrazac RNK ekspresije


Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija hydrolase activity
vezivanje iona metala
deaminase activity
AMP deaminase activity
GO:0001948, GO:0016582 vezivanje za proteine
Ćelijska komponenta citosol
extracellular region
secretory granule lumen
ficolin-1-rich granule lumen
Biološki proces GTP metabolic process
purine ribonucleoside monophosphate biosynthetic process
erythrocyte homeostasis
nucleotide metabolic process
AMP metabolic process
ADP metabolic process
purine-containing compound salvage
IMP salvage
energy homeostasis
ATP metabolic process
AMP catabolic process
IMP biosynthetic process
neutrophil degranulation
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_001172431
NM_000480
NM_001025389
NM_001025390
NM_001172430

NM_001276301
NM_009667
NM_001372439
NM_001372441

RefSeq (bjelančevina)

NP_000471
NP_001020560
NP_001020561
NP_001165901
NP_001165902

NP_001263230
NP_033797
NP_001359368
NP_001359370

Lokacija (UCSC)Chr 11: 10.31 – 10.51 MbChr 7: 110.37 – 110.41 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Ovaj gen kodira člana porodice gena AMP-deaminaza. Kodirani protein je visoko regulirani enzim koji katalizira hidrolitsku deaminaciju adenozin-monofosfata u inozin-monofosfat, tačku grananja u adenilatnom katabolitskom putu. Ovaj gen kodira izoforme eritrocita (E), dok drugi članovi porodice kodiraju izoforme koje prevladavaju u mišićnim (M) i jetrenim (L) ćelijama. Mutacije u ovom genu dovode do klinički asimptomskog, autosomno recesivnog stanja, nedostatka AMP-deaminaze eritrocita. Opisane su i alternativno prerađenesu varijante transkripta koje kodiraju različite izoforme ovog gena.[6]

Aminokiselinska sekvenca

uredi

Dužina polipeptidnog lanca je 767 aminokiselina, a molekulska težina 88.812 Da.[7]

1020304050
MPRQFPKLNISEVDEQVRLLAEKVFAKVLREEDSKDALSLFTVPEDCPIG
QKEAKERELQKELAEQKSVETAKRKKSFKMIRSQSLSLQMPPQQDWKGPP
AASPAMSPTTPVVTGATSLPTPAPYAMPEFQRVTISGDYCAGITLEDYEQ
AAKSLAKALMIREKYARLAYHRFPRITSQYLGHPRADTAPPEEGLPDFHP
PPLPQEDPYCLDDAPPNLDYLVHMQGGILFVYDNKKMLEHQEPHSLPYPD
LETYTVDMSHILALITDGPTKTYCHRRLNFLESKFSLHEMLNEMSEFKEL
KSNPHRDFYNVRKVDTHIHAAACMNQKHLLRFIKHTYQTEPDRTVAEKRG
RKITLRQVFDGLHMDPYDLTVDSLDVHAGRQTFHRFDKFNSKYNPVGASE
LRDLYLKTENYLGGEYFARMVKEVARELEESKYQYSEPRLSIYGRSPEEW
PNLAYWFIQHKVYSPNMRWIIQVPRIYDIFRSKKLLPNFGKMLENIFLPL
FKATINPQDHRELHLFLKYVTGFDSVDDESKHSDHMFSDKSPNPDVWTSE
QNPPYSYYLYYMYANIMVLNNLRRERGLSTFLFRPHCGEAGSITHLVSAF
LTADNISHGLLLKKSPVLQYLYYLAQIPIAMSPLSNNSLFLEYSKNPLRE
FLHKGLHVSLSTDDPMQFHYTKEALMEEYAIAAQVWKLSTCDLCEIARNS
VLQSGLSHQEKQKFLGQNYYKEGPEGNDIRKTNVAQIRMAFRYETLCNEL
SFLSDAMKSEEITALTN

Modelni organizmi

uredi
Fenotip mutantnog nokaut-miša Ampd3
Svojstvo Fenotip
Vijabilnost homozigota Normalan
Studija recesivne letalnosti Normalan
Plodnost Normalan
Tjelesna težina Normalan
Test otvorenog polja: anksioznost Normalan
Neurološka procjena Normalan
Snaga stiska Normalan
Test vruće ploče Normalan
Dismorfologija Normalan
Indirektna kalorimetrija Normalan
Test tolerancije glukoze Normalan
Slušni odgovor moždanog stabla Normalan
DEXA Normalan
Radiografija Normalan
Tjelesna temperatura Normalan
Morfologija oka Normalan
Klinička hemija (nalaz) Normalan
Plazmatski imunoglobulini Nenormalan
Hematologija Normalan
Leukociti periferne krvi Nenormalan
Mikronukleus test Normalan
Težina srca Normalan
Histopatologija mozga Nenormalan
Histopatologija oka Normalan
MikroCT i kvantitativni faksitron Nenormalan
Salmonella infekcija Normal[8]
Citrobacter infekcija Normal[9]
Svi testovi i analize su iz [10][11]

U proučavanju PNPO funkcije, korišteni su modelni organizmi. Uvjetna linija nokaut-miševa, zvana Pnpotm1a (KOMP) Wtsi,[12][13] generirana je kao dio programa Međunarosnog konzorcija za nokaut-miševe – visokopropusnog projekta mutageneze za generiranje i distribuciju životinjskih modela bolesti zainteresiranim naučnicima.[14][15][16]

Muške i ženske životinje prolazile su standardizirani fenotipski skrining, kako bi se utvrdili efekti delecije.[10][17] Od 24 izvedena testa ina mutantnim miševima, uočene su dvije značajne abnormalnosti.[10] Tokom gestacije, nije utvrđen homozigotni mutantni embrion, pa tako nijedan nije preživio do odvikavanja. Preostali testovi su izvedeni na mutiranim heterozigotnim odraslim miševima; opažene su četiri značajijne abnormalnosti kod ovih životinja.[10] Druga mišja linija, zvana Ampd3T689A, generirana je mutagenezom ENU.[18] Ovaj miš nosi mutaciju koja povećava funkciju AMPD3. Mutantne životinje imaju značajno kraći životni vijek crvenih krvnih ćelija, cikličku eritropoezu, splenomegaliju i otpornost na infekciju sa Plasmodium chabaudi .

Reference

uredi
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000133805 - Ensembl, maj 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000005686 - Ensembl, maj 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Mahnke-Zizelman DK, Sabina RL (oktobar 1992). "Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons". The Journal of Biological Chemistry. 267 (29): 20866–77. doi:10.1016/S0021-9258(19)36768-7. PMID 1400401.
  6. ^ a b "Entrez Gene: AMPD3 adenosine monophosphate deaminase (isoform E)".
  7. ^ "UniProt, Q01432". Pristupljeno 15. 8. 2021.
  8. ^ "Salmonella infection data for Pnpo". Wellcome Trust Sanger Institute.
  9. ^ "Citrobacter infection data for Pnpo". Wellcome Trust Sanger Institute.
  10. ^ a b c d Gerdin AK (2010). "The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice". Acta Ophthalmologica. 88: 925–7. doi:10.1111/j.1755-3768.2010.4142.x. S2CID 85911512.
  11. ^ Mouse Resources Portal, Wellcome Trust Sanger Institute.
  12. ^ "International Knockout Mouse Consortium". Arhivirano s originala, 3. 4. 2012. Pristupljeno 15. 8. 2021.
  13. ^ "Mouse Genome Informatics".
  14. ^ Skarnes, W. C.; Rosen, B.; West, A. P.; Koutsourakis, M.; Bushell, W.; Iyer, V.; Mujica, A. O.; Thomas, M.; Harrow, J.; Cox, T.; Jackson, D.; Severin, J.; Biggs, P.; Fu, J.; Nefedov, M.; De Jong, P. J.; Stewart, A. F.; Bradley, A. (2011). "A conditional knockout resource for the genome-wide study of mouse gene function". Nature. 474 (7351): 337–342. doi:10.1038/nature10163. PMC 3572410. PMID 21677750.
  15. ^ Dolgin E (2011). "Mouse library set to be knockout". Nature. 474 (7351): 262–3. doi:10.1038/474262a. PMID 21677718.
  16. ^ Collins FS, Rossant J, Wurst W (2007). "A Mouse for All Reasons". Cell. 128 (1): 9–13. doi:10.1016/j.cell.2006.12.018. PMID 17218247. S2CID 18872015.
  17. ^ van der Weyden L, White JK, Adams DJ, Logan DW (2011). "The mouse genetics toolkit: revealing function and mechanism". Genome Biol. 12 (6): 224. doi:10.1186/gb-2011-12-6-224. PMC 3218837. PMID 21722353.
  18. ^ Hortle E, Nijagal B, Bauer DC, Jensen LM, Ahn SB, Cockburn IA, Lampkin S, Tull D, McConville MJ, McMorran BJ, Foote SJ, Burgio G (septembar 2016). "Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice". Blood. 128 (9): 1290–301. doi:10.1182/blood-2015-09-666834. PMC 5009516. PMID 27465915.

Dopunska literatura

uredi
  • Zydowo MM (1994). "Regulatory effects of the lipid-cytosolic enzyme interaction: AMP deaminase". Acta Biochimica Polonica. 40 (4): 429–32. doi:10.18388/abp.1993_4780. PMID 8140814.
  • Yamada Y, Goto H, Ogasawara N (novembar 1992). "Cloning and nucleotide sequence of the cDNA encoding human erythrocyte-specific AMP deaminase". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1171 (1): 125–8. doi:10.1016/0167-4781(92)90153-Q. PMID 1420359.
  • Ogasawara N, Goto H, Yamada Y, Nishigaki I, Itoh T, Hasegawa I, Park KS (januar 1987). "Deficiency of AMP deaminase in erythrocytes". Human Genetics. 75 (1): 15–8. doi:10.1007/BF00273831 (neaktivno 31. 5. 2021). PMID 3804327.CS1 održavanje: DOI nije aktivan od 2021 (link)
  • Yamada Y, Goto H, Murase T, Ogasawara N (decembar 1994). "Molecular basis for human erythrocyte AMP deaminase deficiency: screening for the major point mutation and identification of other mutations". Human Molecular Genetics. 3 (12): 2243–5. doi:10.1093/hmg/3.12.2243. PMID 7881427.
  • Yamada Y, Goto H, Ogasawara N (februar 1994). "A point mutation responsible for human erythrocyte AMP deaminase deficiency". Human Molecular Genetics. 3 (2): 331–4. doi:10.1093/hmg/3.2.331. PMID 8004104.
  • Mahnke-Zizelman DK, Eddy R, Shows TB, Sabina RL (april 1996). "Characterization of the human AMPD3 gene reveals that 5' exon usage is subject to transcriptional control by three tandem promoters and alternative splicing". Biochimica et Biophysica Acta. 1306 (1): 75–92. doi:10.1016/0167-4781(95)00231-6. PMID 8611627.
  • Fortuin FD, Morisaki T, Holmes EW (juli 1996). "Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle". Proceedings of the Association of American Physicians. 108 (4): 329–33. PMID 8863347.
  • Mahnke-Zizelman DK, D'cunha J, Wojnar JM, Brogley MA, Sabina RL (septembar 1997). "Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type". The Biochemical Journal. 326 ( Pt 2) (2): 521–9. doi:10.1042/bj3260521. PMC 1218700. PMID 9291127.
  • Yamada Y, Goto H, Wakamatsu N, Ogasawara N (2001). "A rare case of complete human erythrocyte AMP deaminase deficiency due to two novel missense mutations in AMPD3". Human Mutation. 17 (1): 78. doi:10.1002/1098-1004(2001)17:1<78::AID-HUMU21>3.0.CO;2-B. PMID 11139257.
  • Mahnke-Zizelman DK, Sabina RL (novembar 2002). "N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E". The Journal of Biological Chemistry. 277 (45): 42654–62. doi:10.1074/jbc.M203473200. PMID 12213808. S2CID 25657474.
  • Tomikura Y, Hisatome I, Tsuboi M, Yamawaki M, Shimoyama M, Yamamoto Y, Sasaki N, Ogino K, Igawa O, Shigemasa C, Ishiguro S, Ohgi S, Nanba E, Shiota G, Morisaki H, Morisaki T, Kitakaze M (mart 2003). "Coordinate induction of AMP deaminase in human atrium with mitochondrial DNA deletion" (PDF). Biochemical and Biophysical Research Communications. 302 (2): 372–6. doi:10.1016/S0006-291X(03)00160-8. PMID 12604357. Arhivirano s originala (PDF), 13. 3. 2022. Pristupljeno 15. 8. 2021.
  • Mahnke DK, Sabina RL (april 2005). "Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide". Biochemistry. 44 (14): 5551–9. doi:10.1021/bi048121p. PMID 15807549.
  • Sabina RL, Waldenström A, Ronquist G (maj 2006). "The contribution of Ca+ calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency". Haematologica. 91 (5): 652–5. PMID 16670071.

Vanjski linkovi

uredi